カテゴリー： QYResearch, 世界

世界の女性用避妊薬市場

◆英語タイトル：Global Female Contraception Drug Market Professional Survey Report 2019
◆商品コード：DATA909X07649
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2019年11月15日（※2024年版があります。お問い合わせください）
◆ページ数：106
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,500 ⇒換算￥518,000	見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）	USD5,250 ⇒換算￥777,000	見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）	USD7,000 ⇒換算￥1,036,000	見積依頼/購入/質問フォーム

★QYResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※本調査レポートは、女性用避妊薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他に、用途別には、クリニック、病院、在宅ケアにセグメント区分し、女性用避妊薬の世界市場を分析しました。

・エグゼクティブ・サマリー
・女性用避妊薬の世界市場概要
・女性用避妊薬の製造コスト構成分析
・女性用避妊薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・女性用避妊薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・女性用避妊薬のセグメント分析（種類別）
（AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他）
・女性用避妊薬のセグメント分析（用途別）
（クリニック、病院、在宅ケア）
・女性用避妊薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Addex Therapeutics Ltd、Agile Therapeutics Inc、Bayer AG、Evofem Inc、Hervana Ltd、Mithra Pharmaceuticals SA、Orbis Biosciences Inc、Teva Pharmaceutical Industries Ltd、Viramal Ltd、）
・女性用避妊薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...

【レポートの概要】

The global Female Contraception Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Female Contraception Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Female Contraception Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Female Contraception Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Female Contraception Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer AG
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
AG-890
Amphora
BAY-1007626
Drospirenone
Others

Segment by Application
Clinic
Hospital
Homecare

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Female Contraception Drug
1.1 Definition of Female Contraception Drug
1.2 Female Contraception Drug Segment by Type
1.2.1 Global Female Contraception Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 AG-890
1.2.3 Amphora
1.2.4 BAY-1007626
1.2.5 Drospirenone
1.2.6 Others
1.3 Female Contraception Drug Segment by Applications
1.3.1 Global Female Contraception Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Global Female Contraception Drug Overall Market
1.4.1 Global Female Contraception Drug Revenue (2014-2025)
1.4.2 Global Female Contraception Drug Production (2014-2025)
1.4.3 North America Female Contraception Drug Status and Prospect (2014-2025)
1.4.4 Europe Female Contraception Drug Status and Prospect (2014-2025)
1.4.5 China Female Contraception Drug Status and Prospect (2014-2025)
1.4.6 Japan Female Contraception Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Female Contraception Drug Status and Prospect (2014-2025)
1.4.8 India Female Contraception Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Female Contraception Drug
2.3 Manufacturing Process Analysis of Female Contraception Drug
2.4 Industry Chain Structure of Female Contraception Drug

3 Development and Manufacturing Plants Analysis of Female Contraception Drug
3.1 Capacity and Commercial Production Date
3.2 Global Female Contraception Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Female Contraception Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Female Contraception Drug Production and Capacity Analysis
4.2 Female Contraception Drug Revenue Analysis
4.3 Female Contraception Drug Price Analysis
4.4 Market Concentration Degree

5 Female Contraception Drug Regional Market Analysis
5.1 Female Contraception Drug Production by Regions
5.1.1 Global Female Contraception Drug Production by Regions
5.1.2 Global Female Contraception Drug Revenue by Regions
5.2 Female Contraception Drug Consumption by Regions
5.3 North America Female Contraception Drug Market Analysis
5.3.1 North America Female Contraception Drug Production
5.3.2 North America Female Contraception Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Female Contraception Drug Import and Export
5.4 Europe Female Contraception Drug Market Analysis
5.4.1 Europe Female Contraception Drug Production
5.4.2 Europe Female Contraception Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Female Contraception Drug Import and Export
5.5 China Female Contraception Drug Market Analysis
5.5.1 China Female Contraception Drug Production
5.5.2 China Female Contraception Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Female Contraception Drug Import and Export
5.6 Japan Female Contraception Drug Market Analysis
5.6.1 Japan Female Contraception Drug Production
5.6.2 Japan Female Contraception Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Female Contraception Drug Import and Export
5.7 Southeast Asia Female Contraception Drug Market Analysis
5.7.1 Southeast Asia Female Contraception Drug Production
5.7.2 Southeast Asia Female Contraception Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Female Contraception Drug Import and Export
5.8 India Female Contraception Drug Market Analysis
5.8.1 India Female Contraception Drug Production
5.8.2 India Female Contraception Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Female Contraception Drug Import and Export

6 Female Contraception Drug Segment Market Analysis (by Type)
6.1 Global Female Contraception Drug Production by Type
6.2 Global Female Contraception Drug Revenue by Type
6.3 Female Contraception Drug Price by Type

7 Female Contraception Drug Segment Market Analysis (by Application)
7.1 Global Female Contraception Drug Consumption by Application
7.2 Global Female Contraception Drug Consumption Market Share by Application (2014-2019)

8 Female Contraception Drug Major Manufacturers Analysis
8.1 Addex Therapeutics Ltd
8.1.1 Addex Therapeutics Ltd Female Contraception Drug Production Sites and Area Served
8.1.2 Addex Therapeutics Ltd Product Introduction, Application and Specification
8.1.3 Addex Therapeutics Ltd Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Agile Therapeutics Inc
8.2.1 Agile Therapeutics Inc Female Contraception Drug Production Sites and Area Served
8.2.2 Agile Therapeutics Inc Product Introduction, Application and Specification
8.2.3 Agile Therapeutics Inc Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bayer AG
8.3.1 Bayer AG Female Contraception Drug Production Sites and Area Served
8.3.2 Bayer AG Product Introduction, Application and Specification
8.3.3 Bayer AG Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Evofem Inc
8.4.1 Evofem Inc Female Contraception Drug Production Sites and Area Served
8.4.2 Evofem Inc Product Introduction, Application and Specification
8.4.3 Evofem Inc Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Hervana Ltd
8.5.1 Hervana Ltd Female Contraception Drug Production Sites and Area Served
8.5.2 Hervana Ltd Product Introduction, Application and Specification
8.5.3 Hervana Ltd Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Mithra Pharmaceuticals SA
8.6.1 Mithra Pharmaceuticals SA Female Contraception Drug Production Sites and Area Served
8.6.2 Mithra Pharmaceuticals SA Product Introduction, Application and Specification
8.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Orbis Biosciences Inc
8.7.1 Orbis Biosciences Inc Female Contraception Drug Production Sites and Area Served
8.7.2 Orbis Biosciences Inc Product Introduction, Application and Specification
8.7.3 Orbis Biosciences Inc Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Teva Pharmaceutical Industries Ltd
8.8.1 Teva Pharmaceutical Industries Ltd Female Contraception Drug Production Sites and Area Served
8.8.2 Teva Pharmaceutical Industries Ltd Product Introduction, Application and Specification
8.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Viramal Ltd
8.9.1 Viramal Ltd Female Contraception Drug Production Sites and Area Served
8.9.2 Viramal Ltd Product Introduction, Application and Specification
8.9.3 Viramal Ltd Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Female Contraception Drug Market
9.1 Global Female Contraception Drug Market Trend Analysis
9.1.1 Global Female Contraception Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Female Contraception Drug Regional Market Trend
9.2.1 North America Female Contraception Drug Forecast 2019-2025
9.2.2 Europe Female Contraception Drug Forecast 2019-2025
9.2.3 China Female Contraception Drug Forecast 2019-2025
9.2.4 Japan Female Contraception Drug Forecast 2019-2025
9.2.5 Southeast Asia Female Contraception Drug Forecast 2019-2025
9.2.6 India Female Contraception Drug Forecast 2019-2025
9.3 Female Contraception Drug Market Trend (Product Type)
9.4 Female Contraception Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Female Contraception Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Female Contraception Drug
Table Global Female Contraception Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Female Contraception Drug Production Market Share by Types in 2018
Figure AG-890 Product Picture
Figure Amphora Product Picture
Figure BAY-1007626 Product Picture
Figure Drospirenone Product Picture
Figure Others Product Picture
Table Global Female Contraception Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Female Contraception Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Homecare
Figure Global Female Contraception Drug Revenue (Million USD) (2014-2025)
Figure Global Female Contraception Drug Production (K Pcs) (2014-2025)
Figure North America Female Contraception Drug Market Size (Million USD) (2014-2025)
Figure Europe Female Contraception Drug Market Size (Million USD) (2014-2025)
Figure China Female Contraception Drug Market Size (Million USD) (2014-2025)
Figure Japan Female Contraception Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Female Contraception Drug Market Size (Million USD) (2014-2025)
Figure India Female Contraception Drug Market Size (Million USD) (2014-2025)
Table Female Contraception Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Female Contraception Drug in 2018
Figure Manufacturing Process Analysis of Female Contraception Drug
Figure Industry Chain Structure of Female Contraception Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Female Contraception Drug Manufacturing Plants Distribution
Table Female Contraception Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Female Contraception Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Female Contraception Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Female Contraception Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Female Contraception Drug Production Share by Manufacturers in 2018
Table Female Contraception Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Female Contraception Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Female Contraception Drug Revenue Share by Manufacturers in 2018
Table Female Contraception Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Female Contraception Drug Production by Regions 2014-2019 (K Pcs)
Table Global Female Contraception Drug Production Market Share by Regions 2014-2019
Figure Global Female Contraception Drug Production Market Share by Regions in 2018
Table Global Female Contraception Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Female Contraception Drug Revenue Market Share by Regions 2014-2019
Figure Global Female Contraception Drug Revenue Market Share by Regions in 2018
Table Global Female Contraception Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Female Contraception Drug Consumption Market Share by Regions 2014-2019
Figure North America Female Contraception Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Female Contraception Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Female Contraception Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Female Contraception Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Female Contraception Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Female Contraception Drug Production, Consumption Import and Export (K Pcs)
Figure China Female Contraception Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Female Contraception Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Female Contraception Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Female Contraception Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Female Contraception Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Female Contraception Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Female Contraception Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Female Contraception Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Female Contraception Drug Production, Consumption Import and Export (K Pcs)
Figure India Female Contraception Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Female Contraception Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Female Contraception Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Female Contraception Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Female Contraception Drug Market Share by Application (2014-2019)
Table Addex Therapeutics Ltd Female Contraception Drug Production Sites and Area Served
Table Addex Therapeutics Ltd Female Contraception Drug Product Introduction, Application and Specification
Table Addex Therapeutics Ltd Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Addex Therapeutics Ltd Female Contraception Drug Production Growth Rate (2014-2019)
Table Addex Therapeutics Ltd Female Contraception Drug Production Market Share (2014-2019)
Figure Addex Therapeutics Ltd Female Contraception Drug Revenue Market Share (2014-2019)
Table Addex Therapeutics Ltd Female Contraception Drug Main Business and Markets Served
Table Agile Therapeutics Inc Female Contraception Drug Production Sites and Area Served
Table Agile Therapeutics Inc Female Contraception Drug Product Introduction, Application and Specification
Table Agile Therapeutics Inc Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Agile Therapeutics Inc Female Contraception Drug Production Growth Rate (2014-2019)
Table Agile Therapeutics Inc Female Contraception Drug Production Market Share (2014-2019)
Figure Agile Therapeutics Inc Female Contraception Drug Revenue Market Share (2014-2019)
Table Agile Therapeutics Inc Female Contraception Drug Main Business and Markets Served
Table Bayer AG Female Contraception Drug Production Sites and Area Served
Table Bayer AG Female Contraception Drug Product Introduction, Application and Specification
Table Bayer AG Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer AG Female Contraception Drug Production Growth Rate (2014-2019)
Table Bayer AG Female Contraception Drug Production Market Share (2014-2019)
Figure Bayer AG Female Contraception Drug Revenue Market Share (2014-2019)
Table Bayer AG Female Contraception Drug Main Business and Markets Served
Table Evofem Inc Female Contraception Drug Production Sites and Area Served
Table Evofem Inc Female Contraception Drug Product Introduction, Application and Specification
Table Evofem Inc Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Evofem Inc Female Contraception Drug Production Growth Rate (2014-2019)
Table Evofem Inc Female Contraception Drug Production Market Share (2014-2019)
Figure Evofem Inc Female Contraception Drug Revenue Market Share (2014-2019)
Table Evofem Inc Female Contraception Drug Main Business and Markets Served
Table Hervana Ltd Female Contraception Drug Production Sites and Area Served
Table Hervana Ltd Female Contraception Drug Product Introduction, Application and Specification
Table Hervana Ltd Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hervana Ltd Female Contraception Drug Production Growth Rate (2014-2019)
Table Hervana Ltd Female Contraception Drug Production Market Share (2014-2019)
Figure Hervana Ltd Female Contraception Drug Revenue Market Share (2014-2019)
Table Hervana Ltd Female Contraception Drug Main Business and Markets Served
Table Mithra Pharmaceuticals SA Female Contraception Drug Production Sites and Area Served
Table Mithra Pharmaceuticals SA Female Contraception Drug Product Introduction, Application and Specification
Table Mithra Pharmaceuticals SA Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Mithra Pharmaceuticals SA Female Contraception Drug Production Growth Rate (2014-2019)
Table Mithra Pharmaceuticals SA Female Contraception Drug Production Market Share (2014-2019)
Figure Mithra Pharmaceuticals SA Female Contraception Drug Revenue Market Share (2014-2019)
Table Mithra Pharmaceuticals SA Female Contraception Drug Main Business and Markets Served
Table Orbis Biosciences Inc Female Contraception Drug Production Sites and Area Served
Table Orbis Biosciences Inc Female Contraception Drug Product Introduction, Application and Specification
Table Orbis Biosciences Inc Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Orbis Biosciences Inc Female Contraception Drug Production Growth Rate (2014-2019)
Table Orbis Biosciences Inc Female Contraception Drug Production Market Share (2014-2019)
Figure Orbis Biosciences Inc Female Contraception Drug Revenue Market Share (2014-2019)
Table Orbis Biosciences Inc Female Contraception Drug Main Business and Markets Served
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Production Sites and Area Served
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Product Introduction, Application and Specification
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Production Market Share (2014-2019)
Figure Teva Pharmaceutical Industries Ltd Female Contraception Drug Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Main Business and Markets Served
Table Viramal Ltd Female Contraception Drug Production Sites and Area Served
Table Viramal Ltd Female Contraception Drug Product Introduction, Application and Specification
Table Viramal Ltd Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Viramal Ltd Female Contraception Drug Production Growth Rate (2014-2019)
Table Viramal Ltd Female Contraception Drug Production Market Share (2014-2019)
Figure Viramal Ltd Female Contraception Drug Revenue Market Share (2014-2019)
Table Viramal Ltd Female Contraception Drug Main Business and Markets Served
Figure Global Female Contraception Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Female Contraception Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Female Contraception Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Female Contraception Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Female Contraception Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Female Contraception Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Female Contraception Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Female Contraception Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Female Contraception Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Female Contraception Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Female Contraception Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Female Contraception Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Female Contraception Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Female Contraception Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Female Contraception Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Female Contraception Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Female Contraception Drug by Application (2019-2025)
Table Female Contraception Drug Distributors List
Table Female Contraception Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

【掲載企業】

Addex Therapeutics Ltd、Agile Therapeutics Inc、Bayer AG、Evofem Inc、Hervana Ltd、Mithra Pharmaceuticals SA、Orbis Biosciences Inc、Teva Pharmaceutical Industries Ltd、Viramal Ltd、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の女性用避妊薬市場(Global Female Contraception Drug Market Professional Survey Report 2019)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp